MedTrace Logo

Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D

NCT00128882 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2009-02-03

No results posted yet for this study

Summary

The purpose of this study is to describe the effect of anti-D on symptoms and platelet count in children suffering from unexplainable low platelet counts, when anti-D is administered as an injection under the skin. The hypothesis is that the injection with anti-D under the skin is as effective as anti-D given in a vein.

Conditions

  • Idiopathic Thrombocytopenic Purpura

Interventions

DRUG

Anti-D

Subcutaneous injection

Sponsors & Collaborators

  • Kjaersgaard, Mimi, M.D.

    collaborator INDIV

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Mimi Kjaersgaard, MD · University of Aarhus, Clinical Institute, Department of Pediatrics

  • Henrik Hasle, MD PhD · Skejby Hospital, University of Aarhus, Department of Pediatrics

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30
Primary Completion
2008-01-31
Completion
2008-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00128882 on ClinicalTrials.gov